+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lung Cancer"

United States Digital Marketing Trends in Non-small Cell Lung Cancer - Product Thumbnail Image

United States Digital Marketing Trends in Non-small Cell Lung Cancer

  • Report
  • November 2023
  • 31 Pages
  • United States
From
From
From
From
Database of Biomarkers Curated from US Oncology Trials, 2021 - Product Thumbnail Image

Database of Biomarkers Curated from US Oncology Trials, 2021

  • Database
  • December 2021
  • United States
From
Oncology Markets for Tyrokinse Kinase Inhibitors - Product Thumbnail Image

Oncology Markets for Tyrokinse Kinase Inhibitors

  • Report
  • October 2021
  • 137 Pages
  • Global
From
Disease Analysis: Non-Small Cell Lung Cancer (NSCLC) - Product Thumbnail Image

Disease Analysis: Non-Small Cell Lung Cancer (NSCLC)

  • Report
  • April 2021
  • 191 Pages
  • Global
Loading Indicator

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies. Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more